Skip to main content
. 2021 Apr 15;11(4):1226–1246.

Figure 5.

Figure 5

Survival prediction of the recurrence-related signature in CGGA_325 dataset. A. Overall survival prediction of the signature in all grade gliomas, lower grade gliomas (LGG, grade II and III), glioblastoma (GBM, grade IV), LGG with IDH-mutant and 1p/19q-codeleted, LGG with IDH-mutant and 1p/19q-intact, LGG with IDH-wildtype, GBM with IDH-mutant, GBM with IDH-wildtype. B. Progression free survival prediction of the signature in all grade gliomas, lower grade gliomas (LGG, grade II and III), glioblastoma (GBM, grade IV), LGG with IDH-mutant and 1p/19q-codeleted, LGG with IDH-mutant and 1p/19q-intact, LGG with IDH-wildtype, GBM with IDH-mutant, GBM with IDH-wildtype. Survival difference was determined by a log-rank test.